BioCentury | Jul 11, 2016
Financial News

Aslan completes venture financing

...KGI VC; Ta Ya Venture Capital; Milestone Capital; Daiwa Corporate Investment Co. Ltd.; China Galaxy; Sagamore BioVentures...
BioCentury | Jul 6, 2016
Financial News

Aslan raises $23M in pre-IPO round

...Ta Ya Ventures, Milestone Capital, Daiwa Taiwan-Japan Biotech Fund and China Galaxy. Existing investors included Sagamore BioVentures...
BioCentury | Dec 14, 2015
Financial News

Aslan completes venture financing

...Temasek Holdings Pte. Ltd.; Tianda Pharmaceuticals Ltd.; Haitong International; Morningside Group ; BioVeda; Cenova Ventures; Sagamore Bioventures WIR...
BioCentury | Dec 8, 2015
Financial News

Aslan raises $34M in series C round

...International also participated, as did existing investors Morningside Group , BioVeda Capital, Cenova Ventures and Sagamore Bioventures...
BioCentury | Oct 28, 2013
Finance

Asian leverage

...Cenova Ventures. New investors Morningside Group and XinChen Ventures joined existing investors BioVeda Capital and Sagamore Bioventures...
BioCentury | Oct 14, 2013
Financial News

Aslan completes venture financing

...10/10/13 Type: Venture financing Raised: $22 million Investors: Cenova Ventures; Morningside Group; XinChen Ventures; BioVeda; Sagamore Bioventures WIR...
BioCentury | Oct 10, 2013
Financial News

Aslan raises $22 million in series B

...investors Morningside Group; and XinChen Ventures also participated along with existing investors BioVeda Capital; and Sagamore Bioventures...
BioCentury | Oct 22, 2012
Company News

BioCryst, Presidio deal

...Leaf Venture Partners; Panorama Capital; Baker Brothers; Ventures West; Bay City Capital; Nexus Medical Partners; Sagamore Bioventures...
BioCentury | Oct 19, 2012
Company News

BioCryst, Presidio combining

...Leaf Venture Partners; Panorama Capital; Baker Brothers; Ventures West; Bay City Capital; Nexus Medical Partners; Sagamore Bioventures...
BioCentury | Oct 3, 2011
Emerging Company Profile

Aslan: A bridge to Phase III

...partners: Array BioPharma Inc. Number of employees: 12 Funds raised: $14 million Investors: BioVeda Capital, Sagamore Bioventures...
Items per page:
1 - 10 of 18
BioCentury | Jul 11, 2016
Financial News

Aslan completes venture financing

...KGI VC; Ta Ya Venture Capital; Milestone Capital; Daiwa Corporate Investment Co. Ltd.; China Galaxy; Sagamore BioVentures...
BioCentury | Jul 6, 2016
Financial News

Aslan raises $23M in pre-IPO round

...Ta Ya Ventures, Milestone Capital, Daiwa Taiwan-Japan Biotech Fund and China Galaxy. Existing investors included Sagamore BioVentures...
BioCentury | Dec 14, 2015
Financial News

Aslan completes venture financing

...Temasek Holdings Pte. Ltd.; Tianda Pharmaceuticals Ltd.; Haitong International; Morningside Group ; BioVeda; Cenova Ventures; Sagamore Bioventures WIR...
BioCentury | Dec 8, 2015
Financial News

Aslan raises $34M in series C round

...International also participated, as did existing investors Morningside Group , BioVeda Capital, Cenova Ventures and Sagamore Bioventures...
BioCentury | Oct 28, 2013
Finance

Asian leverage

...Cenova Ventures. New investors Morningside Group and XinChen Ventures joined existing investors BioVeda Capital and Sagamore Bioventures...
BioCentury | Oct 14, 2013
Financial News

Aslan completes venture financing

...10/10/13 Type: Venture financing Raised: $22 million Investors: Cenova Ventures; Morningside Group; XinChen Ventures; BioVeda; Sagamore Bioventures WIR...
BioCentury | Oct 10, 2013
Financial News

Aslan raises $22 million in series B

...investors Morningside Group; and XinChen Ventures also participated along with existing investors BioVeda Capital; and Sagamore Bioventures...
BioCentury | Oct 22, 2012
Company News

BioCryst, Presidio deal

...Leaf Venture Partners; Panorama Capital; Baker Brothers; Ventures West; Bay City Capital; Nexus Medical Partners; Sagamore Bioventures...
BioCentury | Oct 19, 2012
Company News

BioCryst, Presidio combining

...Leaf Venture Partners; Panorama Capital; Baker Brothers; Ventures West; Bay City Capital; Nexus Medical Partners; Sagamore Bioventures...
BioCentury | Oct 3, 2011
Emerging Company Profile

Aslan: A bridge to Phase III

...partners: Array BioPharma Inc. Number of employees: 12 Funds raised: $14 million Investors: BioVeda Capital, Sagamore Bioventures...
Items per page:
1 - 10 of 18